Updated Jul 16, 2026 · Last SEC filing 2026-05-12
Amneal Pharmaceuticals, Inc. (AMRX) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-12. 3 Form 8-K material event filings were reported by AMRX in the last 90 days. 1 Form 144 notices of proposed sale were filed for AMRX stock. InsiderAlpha tracks every AMRX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001723128 |
|---|
| Form 4 filings (90d) | 9 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-05-12 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Autor Deborah M. | Director | S — Open-market sale | 34.8K | $12.94 | $451K | SEC | |
| MEISTER PAUL M | Director | M — Option exercise | 48.7K | — | — | SEC | |
| George Jeffrey P. | Director | M — Option exercise | 34.8K | — | — | SEC | |
| Yanai Shlomo | Director | M — Option exercise | 34.8K | — | — | SEC | |
| BUCHI J KEVIN | Director | M — Option exercise | 34.8K | — | — | SEC | |
| Autor Deborah M. | Director | M — Option exercise | 34.8K | — | — | SEC | |
| Kiely John | Director | M — Option exercise | 34.8K | — | — | SEC | |
| Patel Gautam | Director | M — Option exercise | 34.8K | — | — | SEC | |
| Nark Ted C | Director | M — Option exercise | 34.8K | — | — | SEC | |
| Patel Chirag K. | President & Co-CEO | M — Option exercise | 92.6K | — | — | SEC | |
| Patel Chintu | Co-CEO | M — Option exercise | 92.6K | — | — | SEC | |
| Daly Jason B. | EVP, Chief Legal Officer | M — Option exercise | 35.9K | — | — | SEC | |
| Patel Chintu | Co-CEO | F — Tax withholding / forfeiture | 29.0K | $13.30 | $385K | SEC | |
| Patel Chirag K. | President & Co-CEO | F — Tax withholding / forfeiture | 37.8K | $13.30 | $503K | SEC | |
| BOYER ANDREW S | Executive Vice President | F — Tax withholding / forfeiture | 19.1K | $13.30 | $255K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Amneal Pharmaceuticals, Inc. (AMRX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Autor Deborah M. | 4 | $451K |
| Kiely John | 3 | — |
| BUCHI J KEVIN | 3 | — |
| Patel Gautam | 3 | — |
| Nark Ted C | 3 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AMRX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live AMRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.